Federal Circuit Grants Panel Rehearing In Label Carve-Out Row

Mealey's (February 11, 2021, 1:32 PM EST) -- WASHINGTON, D.C. — In a two-page order issued Feb. 10, the Federal Circuit U.S. Court of Appeals announced that it will revisit its October 2020 finding that Teva Pharmaceuticals USA Inc. induced infringement of a reissue patent directed to the treatment of chronic heart failure....

Attached Documents

Related Sections